Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Small Pharma Inc (DMT.VN)

Small Pharma Inc (DMT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Small Pharma Inc 6-8 Bonhill Street 3rd Floor London EC2A 4BX GBR

https://www.smallpharma.com P: 779-237-6485

Description:

Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small Pharma is developing N,N-dimethyltryptamine and a pipeline of novel patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders. It has one operating segment, research and development ("R&D") of psychedelic and nonpsychedelic medicine.

Key Statistics

Overview:

Market Capitalization, $K 50,366
Shares Outstanding, K 335,770
Annual Sales, $ 0 K
Annual Net Income, $ -22,836 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,644 K
% of Institutional Shareholders 0.83%

Growth:

1-Year Return -28.57%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date 10/20/23
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Year 16.67%
Dividend Payout Ratio 0.00%

DMT.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -100.50%
Return-on-Assets % -87.66%
Profit Margin % 0.00%
Debt/Equity 0.02
Price/Sales N/A
Price/Book 4.19
Book Value/Share 0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar